ViroCell
ViroCell Biologics manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies (CGTs) to enter clinical trials.
ViroCell Biologics manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies (CGTs) to enter clinical trials.
ViroCell Biologics manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies (CGTs) to enter clinical trials.
Leveraging the team’s 20-year track record of manufacturing more than 100 unique vectors, ViroCell is helping to accelerate the development of crucial, cutting edge therapies so that disease can recede and progress can prevail.
ViroCell is working in partnership with the Royal Free Hospital and Great Ormond Street Hospital.
Website: www.virocell.com
01/04/2022
Pension Insurance Corporation Group Limited (“PICG” or the “Company”), ultimate parent company of Pension Insurance Corporation plc (“PIC”), the specialist insurer of defined benefit pension schemes, today announces its final results for the 12 months to 31 December 2021.
17/01/2022
The Pension SuperFund (“PSF”) today announces the appointment of Michael Clark as its Chief Executive Officer (“CEO”). Michael joins PSF from Shell where he has been Global Head of Pensions, responsible for the governance and administration of all the Group’s pension arrangements.
28/12/2021
Telent has announced that it has acquired the Harlequin Group, a specialist technology services company. Complementing Telent’s existing business operations, building telecom infrastructure for mobile network operators (MNO) and service providers, the acquisition significantly enhances its professional services capability in the site acquisition and design arena.
04/10/2021
London, 4 October 2021 – Pension Insurance Corporation plc (“PIC”), a specialist insurer of defined benefit pension funds, has signed a £2.2 billion pension insurance buy-in with the Trustee of the Metal Box Pension Scheme...
10/08/2021
The Pension Superfund has announced the makeup of its asset and liability management (ALM) committee – unveiling names including Aberdeen Standard Investments chairman Martin Gilbert and former Railpen chief executive Chris Hitchen as part of its team...
25/06/2021
As Armed Forces Day on 26th June fast-approaches, Telent remains committed to helping service leavers transition successfully out of the forces and thrive in the next chapter of their lives.